Search Results - "Verbeke, K."

Refine Results
  1. 1

    Short chain fatty acids in human gut and metabolic health by Blaak, E E, Canfora, E E, Theis, S, Frost, G, Groen, A K, Mithieux, G, Nauta, A, Scott, K, Stahl, B, van Harsselaar, J, van Tol, R, Vaughan, E E, Verbeke, K

    Published in Beneficial microbes (01-09-2020)
    “…Evidence is accumulating that short chain fatty acids (SCFA) play an important role in the maintenance of gut and metabolic health. The SCFA acetate,…”
    Get more information
    Journal Article
  2. 2

    Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients by Bammens, B., Evenepoel, P., Keuleers, H., Verbeke, K., Vanrenterghem, Y.

    Published in Kidney international (01-03-2006)
    “…Based on in vitro data, protein-bound uremic retention solutes have increasingly been recognized to play a pathophysiological role in the uremic syndrome…”
    Get full text
    Journal Article
  3. 3

    In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients by de Jonge, H, de Loor, H, Verbeke, K, Vanrenterghem, Y, Kuypers, D R

    Published in Clinical pharmacology and therapeutics (01-09-2012)
    “…Tacrolimus is metabolized by CYP3A4 and CYP3A5 and is characterized by a narrow therapeutic index and highly variable pharmacokinetics. This cross‐sectional…”
    Get full text
    Journal Article
  4. 4

    Clinical trial: a randomized‐controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis by ARTS, J., HOLVOET, L., CAENEPEEL, P., BISSCHOPS, R., SIFRIM, D., VERBEKE, K., JANSSENS, J., TACK, J.

    Published in Alimentary Pharmacology and Therapeutics (01-11-2007)
    “…Summary Background  Uncontrolled studies suggest benefit of intrapyloric injection of botulinum toxin (botox) for the treatment of gastroparesis, but…”
    Get full text
    Journal Article
  5. 5

    Free p-cresol is associated with cardiovascular disease in hemodialysis patients by Meijers, B.K.I., Bammens, B., De Moor, B., Verbeke, K., Vanrenterghem, Y., Evenepoel, P.

    Published in Kidney international (01-05-2008)
    “…Cardiovascular disease (CVD) is highly prevalent in chronic kidney disease, suggesting that molecules retained in uremia might contribute to this increased…”
    Get full text
    Journal Article
  6. 6

    Relationship between symptoms and ingestion of a meal in functional dyspepsia by Bisschops, R, Karamanolis, G, Arts, J, Caenepeel, P, Verbeke, K, Janssens, J, Tack, J

    Published in Gut (01-11-2008)
    “…A subset of functional dyspepsia (FD) patients report meal-related symptoms, possibly representing a pathophysiologically homogeneous subgroup. The aim of the…”
    Get more information
    Journal Article
  7. 7

    Influence of ghrelin on gastric emptying and meal‐related symptoms in idiopathic gastroparesis by TACK, J., DEPOORTERE, I., BISSCHOPS, R., VERBEKE, K., JANSSENS, J., PEETERS, T.

    Published in Alimentary pharmacology & therapeutics (01-11-2005)
    “…Summary Background : Ghrelin, the endogenous ligand of the growth hormone secretagogue receptor, is released from the stomach. Animal studies suggest that…”
    Get full text
    Journal Article
  8. 8

    CYP3A5 and CYP3A4 but not MDR1 Single‐nucleotide Polymorphisms Determine Long‐term Tacrolimus Disposition and Drug‐related Nephrotoxicity in Renal Recipients by Kuypers, D R J, Jonge, H, Naesens, M, Lerut, E, Verbeke, K, Vanrenterghem, Y

    Published in Clinical pharmacology and therapeutics (01-12-2007)
    “…The impact of CYP3A and MDR1 gene single‐nucleotide polymorphisms on long‐term tacrolimus disposition and drug‐related toxicity has not been assessed. A study…”
    Get full text
    Journal Article
  9. 9

    Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying by Arts, J, Caenepeel, P, Verbeke, K, Tack, J

    Published in Gut (01-04-2005)
    “…Background and aims: Although delayed gastric emptying is considered a major pathophysiological mechanism in functional dyspepsia, the efficacy of prokinetic…”
    Get full text
    Journal Article
  10. 10

    Superior dialytic clearance of β2-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis by Evenepoel, P., Bammens, B., Verbeke, K., Vanrenterghem, Y.

    Published in Kidney international (28-08-2006)
    “…Both residual renal and dialytic clearance confer to the total solute clearance in dialysis patients. Dialytic clearances of the middle molecule…”
    Get full text
    Journal Article
  11. 11

    Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis by Evenepoel, P, Bammens, B, Verbeke, K, Vanrenterghem, Y

    Published in Kidney international (01-08-2006)
    “…Both residual renal and dialytic clearance confer to the total solute clearance in dialysis patients. Dialytic clearances of the middle molecule…”
    Get full text
    Journal Article
  12. 12

    Baseline microbiota activity and initial bifidobacteria counts influence responses to prebiotic dosing in healthy subjects by DE PRETER, V., VANHOUTTE, T., HUYS, G., SWINGS, J., RUTGEERTS, P., VERBEKE, K.

    Published in Alimentary pharmacology & therapeutics (15-03-2008)
    “…Summary Background  Dietary intervention with prebiotics can cause changes in the colonic microbiota and their metabolic activities. Aim  To investigate…”
    Get full text
    Journal Article
  13. 13

    Postprandial symptoms originating from the stomach in functional dyspepsia by Vanheel, H., Vanuytsel, T., Oudenhove, L., Farré, R., Verbeke, K., Tack, J.

    Published in Neurogastroenterology and motility (01-11-2013)
    “…Background Functional dyspepsia (FD) is characterized by chronic epigastric symptoms. The stomach has been held responsible for the generation of symptoms, but…”
    Get full text
    Journal Article
  14. 14

    Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: A pilot study by Evenepoel, P., Bammens, B., Verbeke, K., Vanrenterghem, Y.

    Published in Kidney international (01-07-2006)
    “…Several protein-bound uremic retention solutes (including p-cresol) originate from colonic bacterial fermentation of protein. Higher colonic availability of…”
    Get full text
    Journal Article
  15. 15

    Gastric emptying and different types of reflux in adult patients with cystic fibrosis by Pauwels, A., Blondeau, K., Mertens, V., Farre, R., Verbeke, K., Dupont, L. J., Sifrim, D.

    Published in Alimentary pharmacology & therapeutics (01-10-2011)
    “…Aliment Pharmacol Ther 2011; 34: 799–807 Summary Background  Increased gastro‐oesophageal reflux (GER) is common in patients with cystic fibrosis (CF)…”
    Get full text
    Journal Article
  16. 16

    Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro by Kitazawa, T, De Smet, B, Verbeke, K, Depoortere, I, Peeters, T L

    Published in Gut (01-08-2005)
    “…Background and aims: The gastroprokinetic activities of ghrelin, the natural ligand of the growth hormone secretagogue receptor (GHS-R), prompted us to compare…”
    Get full text
    Journal Article
  17. 17

    The effect of arabinoxylooligosaccharides on upper gastroduodenal motility and hunger ratings in humans by Scarpellini, E., Deloose, E., Vos, R., Francois, I., Delcour, J. A., Broekaert, W. F., Verbeke, K., Tack, J.

    Published in Neurogastroenterology and motility (01-07-2018)
    “…Background and aims Prebiotics such as Arabinoxylooligosaccharides (AXOS) are non‐digestible, fermentable food ingredients stimulating growth/activity of…”
    Get full text
    Journal Article
  18. 18

    Will the 13C‐octanoic acid breath test ever replace scintigraphy as the gold standard to assess gastric emptying? by Verbeke, K.

    Published in Neurogastroenterology and motility (01-10-2009)
    “…The applicability of the 13C‐octanoic acid breath test for the assessment of gastric emptying is discussed. In the current issue of this journal, Keller and…”
    Get full text
    Journal Article
  19. 19

    In Vivo CYP3A Activity Is Significantly Lower in Cyclosporine‐Treated as Compared With Tacrolimus‐Treated Renal Allograft Recipients by Jonge, H, Loor, H, Verbeke, K, Vanrenterghem, Y, Kuypers, D R J

    Published in Clinical pharmacology and therapeutics (01-09-2011)
    “…In vitro studies have identified cyclosporine and tacrolimus as CYP3A inhibitors. In the current study in renal allograft recipients, we used intravenously and…”
    Get full text
    Journal Article
  20. 20

    Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β‐oxidation pathway by De Preter, V., Geboes, K. P., Bulteel, V., Vandermeulen, G., Suenaert, P., Rutgeerts, P., Verbeke, K.

    Published in Alimentary pharmacology & therapeutics (01-09-2011)
    “…Aliment Pharmacol Ther 2011; 34: 526–532 Summary Background  Butyrate, a colonic metabolite of carbohydrates, is considered as the major energy source for the…”
    Get full text
    Journal Article